H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance

Long noncoding RNA-H19 (H19), an imprinted oncofetal gene, has a central role in carcinogenesis. Hitherto, the mechanism by which H19 regulates cancer stem cells, remains elusive. Here we show that breast cancer stem cells (BCSCs) express high levels of H19, and ectopic overexpression of H19 significantly promotes breast cancer cell clonogenicity, migration and mammosphere-forming ability. Conversely, silencing of H19 represses these BCSC properties. In concordance, knockdown of H19 markedly inhibits tumor growth and suppresses tumorigenesis in nude mice. Mechanistically, we found that H19 functions as a competing endogenous RNA to sponge miRNA let-7, leading to an increase in expression of a let-7 target, the core pluripotency factor LIN28, which is enriched in BCSC populations and breast patient samples. Intriguingly, this gain of LIN28 expression can also feedback to reverse the H19 loss-mediated suppression of BCSC properties. Our data also reveal that LIN28 blocks mature let-7 production and, thereby, de-represses H19 expression in breast cancer cells. Appropriately, H19 and LIN28 expression exhibits strong correlations in primary breast carcinomas. Collectively, these findings reveal that lncRNA H19, miRNA let-7 and transcriptional factor LIN28 form a double-negative feedback loop, which has a critical role in the maintenance of BCSCs. Consequently, disrupting this pathway provides a novel therapeutic strategy for breast cancer.

[1]  E. Dees,et al.  The product of the H19 gene may function as an RNA , 1990, Molecular and cellular biology.

[2]  F Poirier,et al.  The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. , 1991, Development.

[3]  N. de Groot,et al.  H19 expression and tumorigenicity of choriocarcinoma derived cell lines. , 1995, Oncogene.

[4]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[5]  T. Dupressoir,et al.  Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. , 2002, Carcinogenesis.

[6]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  G. Dontu,et al.  In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. , 2003, Genes & development.

[8]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[9]  F. Slack,et al.  RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.

[10]  Igor Jurisica,et al.  The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. , 2006, Cancer research.

[11]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[12]  Daniel Birnbaum,et al.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.

[13]  R. Stewart,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[14]  C. Joo,et al.  Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. , 2008, Molecular cell.

[15]  M. Ringnér,et al.  The CD44+/CD24- phenotype is enriched in basal-like breast tumors , 2008, Breast Cancer Research.

[16]  F. Slack,et al.  let-7 microRNAs in development, stem cells and cancer. , 2008, Trends in molecular medicine.

[17]  Y. Tomari,et al.  Drosophila argonaute1 and argonaute2 employ distinct mechanisms for translational repression. , 2009, Molecular cell.

[18]  D. Gilliland,et al.  A radical bailout strategy for cancer stem cells. , 2009, Cell stem cell.

[19]  L. Hood,et al.  Targeting stem cells-clinical implications for cancer therapy. , 2009, Current stem cell research & therapy.

[20]  J. Baselga,et al.  Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  C. Joo,et al.  TUT4 in Concert with Lin28 Suppresses MicroRNA Biogenesis through Pre-MicroRNA Uridylation , 2009, Cell.

[22]  S. Srikantan,et al.  HuR recruits let-7/RISC to repress c-Myc expression. , 2009, Genes & development.

[23]  G. Daley,et al.  Lin28: A MicroRNA Regulator with a Macro Role , 2010, Cell.

[24]  Jianquan Wang,et al.  Lin28-mediated post-transcriptional regulation of Oct4 expression in human embryonic stem cells , 2009, Nucleic acids research.

[25]  J. Rinn,et al.  Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells , 2010, Nature Genetics.

[26]  S. Niclou,et al.  Critical appraisal of the side population assay in stem cell and cancer stem cell research. , 2011, Cell stem cell.

[27]  A. Giatromanolaki,et al.  The CD44+/CD24− phenotype relates to ‘triple-negative’ state and unfavorable prognosis in breast cancer patients , 2011, Medical oncology.

[28]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[29]  S. Miyano,et al.  Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. , 2011, Cancer research.

[30]  Ju-Seog Lee,et al.  LIN28B promotes colon cancer progression and metastasis. , 2011, Cancer research.

[31]  R. Peto,et al.  Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. , 2012, Lancet.

[32]  Xi C. He,et al.  Maternal imprinting at the H19–Igf2 locus maintains adult haematopoietic stem cell quiescence , 2013, Nature.

[33]  Jianbiao Zhou,et al.  LIN28/LIN28B: an emerging oncogenic driver in cancer stem cells. , 2013, The international journal of biochemistry & cell biology.

[34]  I. Henderson,et al.  Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials: Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (Clinical Trial Service Unit (CTSU), Oxford, UK) Lancet 379:432-444, 2012§ , 2013 .

[35]  Yue Wang,et al.  Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. , 2013, Developmental cell.

[36]  Chaochun Liu,et al.  The imprinted H19 lncRNA antagonizes let-7 microRNAs. , 2013, Molecular cell.

[37]  Zhou Yuan,et al.  H19 promotes pancreatic cancer metastasis by derepressing let-7’s suppression on its target HMGA2-mediated EMT , 2014, Tumor Biology.

[38]  Jian Jian Li,et al.  Breast cancer stem cells: Multiple capacities in tumor metastasis. , 2014, Cancer letters.

[39]  Martin Mueller,et al.  The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells , 2014, Nucleic acids research.

[40]  J. Chen,et al.  Alternative splicing in cancer: implications for biology and therapy , 2014, Oncogene.

[41]  Anindya Dutta,et al.  The H19 long noncoding RNA gives rise to microRNAs miR-675-3p and miR-675-5p to promote skeletal muscle differentiation and regeneration , 2014, Genes & development.

[42]  H. Taylor,et al.  Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation , 2014, Oncogene.

[43]  Libing Song,et al.  Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells , 2014, Cell and Tissue Research.

[44]  M. Řezáčová,et al.  Breast Cancer and Cancer Stem Cells: A Mini-Review , 2014, Tumori.

[45]  Faith A. Bazley,et al.  Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells. , 2015, Stem cells and development.

[46]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[47]  G. Daley,et al.  Hallmarks of pluripotency , 2015, Nature.

[48]  E. Adriaenssens,et al.  Enrichment of Human Stem-Like Prostate Cells with s-SHIP Promoter Activity Uncovers a Role in Stemness for the Long Noncoding RNA H19. , 2015, Stem cells and development.

[49]  J. Rinn,et al.  Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer , 2016, Nature Communications.

[50]  Shou-Ching Tang,et al.  The insights of Let‐7 miRNAs in oncogenesis and stem cell potency , 2016, Journal of cellular and molecular medicine.

[51]  J. Lee,et al.  A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth , 2016, Oncotarget.

[52]  H. Xia,et al.  Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells. , 2016, Journal of neurosurgery.